1 - 10 out of 17Page size: 10
  1. 2022

  2. Exercise and Nutritional Interventions in Patients with Advanced Gastroesophageal Cancer: A Systematic Review

    Besseling, J., van Velzen, M., Wierdsma, N., Alonso-Duin, K. S., Weijs, P., May, A. M. & van Laarhoven, H., 2022, (E-pub ahead of print) In: Journal of gastrointestinal cancer.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2021

  4. Use of palliative chemotherapy and icu admissions in gastric and esophageal cancer patients in the last phase of life: A nationwide observational study

    Besseling, J., Reitsma, J., van Erkelens, J. A., Schepens, M. H. J., Siroen, M. P. C., Ziedses des Plantes, C. M. P., van Berge Henegouwen, M. I., Beerepoot, L. V., Voorthuizen, T. V., Zuylen, L. V., Verhoeven, R. H. A. & van Laarhoven, H., 1 Jan 2021, In: Cancers. 13, 1, p. 1-10 10 p., 145.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. 2018

  6. Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy

    Hartgers, M. L., Besseling, J., Stroes, E. S., Wittekoek, J., Rutten, J. H. W., de Graaf, J., Visseren, F. L. J., Imholz, B. P. M., Roeters van Lennep, J. E., Huijgen, R., Kastelein, J. J. P. & Hovingh, G. K., 2018, In: Journal of clinical lipidology. 12, 4, p. 972-980.e1

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2017

  8. Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia

    Besseling, J., Reitsma, J. B., Gaudet, D., Brisson, D., Kastelein, J. J. P., Hovingh, G. K. & Hutten, B. A., 2017, In: European heart journal. 38, 8, p. 565-573

    Research output: Contribution to journal › Article › Academic › peer-review

  9. 2016

  10. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia

    Besseling, J., Huijgen, R., Martin, S. S., Hutten, B. A., Kastelein, J. J. P. & Hovingh, G. K., 2016, In: Atherosclerosis. 246, p. 1-6

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Is there a link between diabetes and cholesterol metabolism?

    Besseling, J. & Hutten, B. A., 2016, In: Expert review of cardiovascular therapy. 14, 3, p. 259-261

    Research output: Contribution to journal › Editorial › Academic › peer-review

  12. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality

    Besseling, J., Hovingh, G. K., Huijgen, R., Kastelein, J. J. P. & Hutten, B. A., 2016, In: Journal of the American College of Cardiology. 68, 3, p. 252-260

    Research output: Contribution to journal › Article › Academic › peer-review

  13. The extended phenotype of familial hypercholesterolemia

    Besseling, J., 2016, 283 p.

    Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  14. 2015

  15. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study

    Kastelein, J. J. P., Besseling, J., Shah, S., Bergeron, J., Langslet, G., Hovingh, G. K., Al-Saady, N., Koeijvoets, M., Hunter, J., Johnson-Levonas, A. O., Fable, J., Sapre, A. & Mitchel, Y., 2015, In: Lancet. 385, 9983, p. 2153-2161

    Research output: Contribution to journal › Article › Academic › peer-review

  16. Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus

    Besseling, J., Kastelein, J. J. P., Defesche, J. C., Hutten, B. A. & Hovingh, G. K., 2015, In: JAMA. 313, 10, p. 1029-1036

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 Next

ID: 41431